MICROFLUIDIC MARKET Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025 © Coherent market Insights. All Rights Reserved REPORT DESCRIPTION Microfluidic Market Overview Microfluidic devices enables the precise processing of micro liter (~0.01-10 µl) samples and allows to perform significant biological or chemical processing such as sampling, pre-processing and measurement involved in an assay within a single chip. Microfluidics aids in handling and examining very small fluid volumes, around micro- (10-6) to atto- (10-18) liter volumes of fluid, which provides several analytical and economic advantages over the conventional assays. Microfluidic devices typically requires 10x times less sample volume, thereby allowing less sample and reagent consumption. Microfluidic devices transfers such small amount of fluid volume through microfluidic channels, which provides higher surface area to volume ratio, which further enhance the heat transfer. Increasing advancements in microfluidics such as labon-a-chip device for DNA amplification, purification, separation and sequencing, and single cell gene-expression profiling is expected to aid in growth of the market. Microfluidic provides enhanced analytical sensitivity, enhanced temperature control, faster reaction time, cost efficiency and allows integration of lab routines in a single device. Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/1086 The global microfluidic market was valued at US$ 2.8 billion in 2016 and is expected to witness a robust CAGR of 19.4% over the forecast period (2017–2025). © Coherent market Insights. All Rights Reserved REPORT DESCRIPTION Rising demand for point-of-care testing to augment microfluidic market growth Point-of-care testing (POC Testing) is medical diagnostic testing performed primarily outside medical care facilities and in close proximity that is at the time and place of patient care. Point-ofcare testing is relatively expensive than regular lab testing; however, it offers appropriate and immediate results for further clinical management. Microfluidic technology primarily offers three advantages to POC diagnostic: smaller sample volume, lower test costs, and faster detection time. Point-of-care testing enables miniaturization and integration of complex functions facilitating their usage in limited resources. Continuous innovation strategy adopted by manufacturers is expected to aid in accelerating growth of the microfluidic market Adoption of microfluidics as a key technology in medical science and biosensing is increasing significantly in the recent past. Manufacturers are focusing on continuous innovation in microfluidic technology such as laboratory-on-a-chip, point-of-care testing, microfluidic enabled drug delivery systems, and microfluidic gradient generators to enhance their product portfolios. Introduction of thermoplastic as a new material for microfluidic device fabrication instead of conventional PDMS polymer, adoption of novel microfluidic flow rate detection method, and advancement in nanoparticle separation using microfluidic devices is further expected to boost the microfluidic market in the near future. Microfluidic techniques are being extensively used to separate micro sized particles such as blood cells, parasites, spores, tumor cells, and bacteria due to its advantages such as low sample volume, low cost, and miniature sample handing with precise control. However, to separate submicron particle, nanofluidics is emerging as a suitable technology for separation. Request a Customization: https://www.coherentmarketinsights.com/insight/request-customization/1086 © Coherent market Insights. All Rights Reserved REPORT DESCRIPTION Major factors influencing growth of the microfluidic market is rising demand for point-of-care (POC) testing and advancements in microfluidic technology to reduce cost of sample analysis and enabling higher efficiency. Moreover, increasing demand for home healthcare to address growing prevalence of diabetes is supporting to growth of the microfluidic market. For instance, in 2017 researchers at the Ewha Womens University developed an endocrine system on chip, based on microfluidic perfused 3D cell-culture chip which detect the drugs for the treatment of diabetes by measuring insulin release over time. According to the statistics published by International Diabetes Federation (IDF), the global prevalence of diabetes is around 424.9 million in 2017, which is expected to increase to 628.6 million in 2045. In addition, increasing innovation in microfluidics technology is further expected to bolster growth of the market. Researchers at the Brigham Young University, in April 2017, developed first 3D-print viable microfluidic device which has size less than 100 micrometers and employed to use in molecular biology, proteomics and cell biology diagnostic technologies. Get Exclusive Discount on this CMI Report: https://www.coherentmarketinsights.com/insight/request-discount/1086 Some of the major players operating in the microfluidic market are Abbott Laboratories, Agilent Technologies, Thermo Fisher Scientific Inc., Qiagen N.V., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Fluidigm Corporation, Danaher Corporation, PerkinElmer Inc., Siemens Healthcare GmbH, and Micronit Microfluidic BV © Coherent market Insights. All Rights Reserved ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES INDUSTRY ANALYSIS CUSTOMIZED RESEARCH SYNDICATED RESEARCH MARKET INTELLIGENCE SERVICES CONSULT STUDIES COUNTRY SPECIFIC STUDIES © Coherent market Insights. All Rights Reserved ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS Global Leading Equipment and System Manufacturers Marketing Consultancies and the Advertising Industry Component Providers and System Integrators Private and Government organization Distributors, Retailors and Value Added Resellers Outsourcing Companies Healthcare IT Solutions Developers Universities and Business Schools. © Coherent market Insights. All Rights Reserved KEY STATS RESEARCH SOLUTIONS 100+ FEASIBILITY STUDIES Insights Published Per Year GLOBAL REPORTS 150+ Consulting Projects Till Date COUNTRY ANALYSIS CONSULT PROJECTS 125+ Clients Worldwide Per Year 110+ SURVEY RESEARCH EXCEL FORECAST DATABASE CUSTOMIZED SOLUTIONS COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: [email protected] For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights [email protected] +1-206-701-6702 © Coherent market Insights. All Rights Reserved
The Global Microfluidic Market, by Material Type (Silicon-Based Microfluidic, Glass-Based Microfluidic, Polymer-Based Microfluidic, and Others), by Application (In Vitro Diagnostic Devices, Drug Delivery Devices and Monitoring Devices), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 2.8 billion in 2016 and is projected to exhibit a CAGR of 19.4% over the forecast period (2017–2025), as highlighted in a new report published by Coherent Market Insights. Increasing adoption of microfluidic technology to produce miniaturized microfluidic chips used in molecular diagnosis and analysis, is expected to boost growth of the microfluidic market. For instance, in March 2016, 908 Devices Inc. launched, ZipChip, a microfluidic device that provides high quality separation possibilities to mass spectroscopy enabling fast analysis for a broader range of biomolecules.
© Copyright 2024 Paperzz
